Security key
53630X203
Lipocine Inc. - Common Stock, par value $0.0001 per share (LPCN)
CUSIP: 53630X203
Q4 2025 13F Holders as of 31 Dec 2025
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 8,072,317
- Total 13F shares
- 1,629,909
- Share change
- +570,602
- Total reported value
- $13,088,240
- Price per share
- $8.03
- Number of holders
- 25
- Value change
- +$4,710,434
- Number of buys
- 13
- Number of sells
- 6
Report period
Q4 2025
Institutions
25
Top holders
10
LPCN full security history
Newer quarter: Q1 2026
Previous quarter: Q3 2025
Lipocine Inc. SEC filings
Lipocine Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 53630X203
Recent filing periods:
Top shareholders of LPCN - Lipocine Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
2.7%
|
221,867
|
$634,539 | — | 30 Sep 2025 | |
| BlackRock, Inc. |
13F
|
Company |
1.1%
|
89,272
|
$254,425 | — | 30 Sep 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.76%
|
61,076
|
$174,703 | — | 30 Sep 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.58%
|
46,761
|
$133,736 | — | 30 Sep 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.45%
|
36,097
|
$102,876 | — | 30 Sep 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.23%
|
18,626
|
$53,270 | — | 30 Sep 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.18%
|
14,247
|
$40,746 | — | 30 Sep 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.16%
|
13,160
|
$37,506 | — | 30 Sep 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.15%
|
12,140
|
$34,720 | — | 30 Sep 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.12%
|
9,412
|
$26,824 | — | 30 Sep 2025 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.03%
|
2,268
|
$6,458 | — | 30 Sep 2025 | |
| UBS Group AG |
13F
|
Company |
0.02%
|
1,766
|
$5,034 | — | 30 Sep 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
1,170
|
$3,334 | — | 30 Sep 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
575
|
$1,639 | — | 30 Sep 2025 | |
| CALDWELL SUTTER CAPITAL, INC. |
13F
|
Company |
0.01%
|
471
|
$1,342 | — | 30 Sep 2025 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0%
|
162
|
$463 | — | 30 Sep 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0%
|
67
|
$191 | — | 30 Sep 2025 | |
| FMR LLC |
13F
|
Company |
0%
|
59
|
$169 | — | 30 Sep 2025 | |
| Tidemark, LLC |
13F
|
Company |
0%
|
59
|
$168 | — | 30 Sep 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
49
|
$139 | — | 30 Sep 2025 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
3
|
$9 | — | 30 Sep 2025 | |
| Krista Fogarty |
3/4/5
|
Principal Accounting Officer |
—
class O/S missing
|
40,146
|
$168,613 | — | 18 Dec 2025 | |
| Morgan R. Brown |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
176,000
|
$46,746 | — | 07 Dec 2021 | |
| Jeffrey Arvin Fink |
3/4/5
|
Director |
—
class O/S missing
|
11,526
|
$36,883 | — | 04 Jun 2025 | |
| Richard Dana Ono |
3/4/5
|
Director |
—
class O/S missing
|
11,526
|
$36,883 | — | 04 Jun 2025 | |
| George Nomikos |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
125,000
|
$33,200 | — | 01 Nov 2022 | |
| Jill M. Jene |
3/4/5
|
Director |
—
class O/S missing
|
7,174
|
$22,956 | — | 04 Jun 2025 | |
| Spyros Papapetropoulos |
3/4/5
|
Director |
—
class O/S missing
|
7,174
|
$22,956 | — | 04 Jun 2025 |
Institutional Holders of Lipocine Inc. - Common Stock, par value $0.0001 per share (LPCN) as of Q4 2025
As of 31 Dec 2025,
Lipocine Inc. - Common Stock, par value $0.0001 per share (LPCN) was held by
25 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,629,909 shares.
The largest 10 holders included
Squadron Capital Management LLC, DIADEMA PARTNERS LP, VANGUARD GROUP INC, Ikarian Capital, LLC, BlackRock, Inc., Persistent Asset Partners Ltd, GEODE CAPITAL MANAGEMENT, LLC, BOOTHBAY FUND MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, and SUSQUEHANNA INTERNATIONAL GROUP, LLP.
This page lists
25
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
21
Q4 2025 holders
25
Holder diff
4
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q4 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.